SecBot SecBot

DXCM

DEXCOM INC
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001093557 Healthcare & Medical Devices
$81.88 −1.45 (−1.74%)
Nov 16 4:00 PM ET · prev $83.33
Market cap
$30.4B
Large cap
Consensus
Buy
89% Buy or better · 36 analysts
Median target
$96.50
+18% · range $79.00–120.00
1 year
+40.0%
from $58.49 · Nov 17
30 days
−4.8%
from $86.04
52-week range
$57.56–92.34
−11% from high · low Apr 29
Avg volume 20D
5.01M
shares / day
Short interest
15.93M
≈4.3% of shares · +1.6%
Days to cover
2.8
at average volume
Insider net
−$12.1M
0 buyers · 8 sellers · since May 21
New fund stakes
4
Q2 2026 13F · 3 exits
Filing reports
16
analyzed by SecBot
SecBot read MIXED 8 reports · 90 days
Balance 1 bearish · 1 bullish · 6 neutral oldest → newest, height = score
Avg score ·High conf. 6/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • May 7 to May 15 ▼ 2 sells: Michael McCaul, Ro Khanna sold $1,001 - $15,000, last disclosed Jun 11
  • Jun 3 to Jun 4 ▼ 2 days of insider sells: $722.6K by 1 insider, avg $73.56
  • Jun 30 ▲ 4 funds open new positions (13F)
  • Jul 15 to Jul 20 ▼ 2 days of insider sells: $2.2M by 2 insiders, avg $76.21
  • Jul 31 to Aug 3 ▼ 2 days of insider sells: $330.6K by 1 insider, avg $82.66
  • Aug 12 to Aug 27 ▼ 4 days of insider sells: $2.9M by 4 insiders, avg $89.92
  • Sep 10 to Sep 15 ▼ 3 days of insider sells: $1.1M by 3 insiders, avg $83.83
  • Sep 28 ▼ 1 insider sell $221.0K at $86.15
  • Oct 7 Barclays initiates
  • Oct 15 ▼ 1 insider sell $145.3K at $85.48
  • Oct 27 ▼ 1 insider sell $201.7K at $78.62
  • Oct 29 ▲ Dexcom reported Q3 2026 revenue of $1.344B (up 11% YoY), above the $…

Signal stack

Where each data set points today.

  • InsidersBEARISH

    8 insiders sold $12.1M.

  • InstitutionsBULLISH

    Q2 2026: 60 added (4 new), 40 trimmed or exited. Largest new: Capitolis Liquid Global Markets $44.8M, Capital International Investors $44.6M.

  • AnalystsBULLISH

    32 of 36 rate it Buy or better. Median target $96.50 (+18%).

  • Short sellersSTEADY

    Short interest +1.6% to 15.93M shares. 2.8 days to cover, ≈4.3% of shares.

  • TrendDOWNTREND

    3% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Oct 24.

Who's buying

13F· Q2 2026
4
new positions
3
exits
$119.4M
in new stakes
FundMoveSharesValue
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPDOUBLED6,873,273$462.9M
UBS Group AGADD6,065,779$408.5M
Castle Hook Partners LPDOUBLED3,870,342$260.7M
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ADD3,560,621$240.9M
JPMORGAN CHASE & COTRIM3,325,095$232.7M
DEUTSCHE BANK AG\TRIM2,435,559$164.0M
BNP PARIBAS FINANCIAL MARKETSADD2,268,607$152.8M
PRICE T ROWE ASSOCIATES INC /MD/ADD2,238,713$150.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

36 analysts
Buy 89% rate it Buy or better
Strong Buy15Buy17Hold4Sell0Strong Sell0
12-month targets · 26 analysts

Price is inside the target range. Median implies +18%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Oct 30, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 30, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Oct 30, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 30, 2026Barclays
MAINTAIN
MAINTAINOverweight
Oct 30, 2026StoneX
MAINTAIN
MAINTAINBuy
Oct 12, 2026BTIG
MAINTAIN
MAINTAINBuy

Washington

Corporate Lobbying

34 lobbying filings and 1 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
bought · 0 insiders
$12.1M
sold · 8 insiders
DateInsiderTypeValue
Nov 8, 2026
Leach Jacob Steven
President, CEO, and Director
Nov 8, 2026
TAX W/H$115.2K
Nov 8, 2026
Brown Michael Jon
EVP Chief Legal Compliance Off
Nov 8, 2026
TAX W/H$115.2K
Nov 8, 2026
Stern Sadie
EVP Chief People & Culture Off
Nov 8, 2026
TAX W/H$115.2K
Nov 8, 2026
Sylvain Jereme M
EVP, COO & CFO
Nov 8, 2026
TAX W/H$115.2K
Oct 30, 2026
Ashley Euan A.
Director
Oct 30, 2026
GIFT2,389 sh
Oct 27, 2026
Stern Sadie
EVP Chief People & Culture Off
Oct 27, 2026
SELL$201.7K
Oct 15, 2026
Brown Michael Jon
EVP Chief Legal Compliance Off
Oct 15, 2026
SELL$145.3K
Sep 28, 2026
Stern Sadie
EVP Chief People & Culture Off
Sep 28, 2026
SELL$221.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Congressional trades
DXCM trades disclosed by members of Congress, with disclosure delay.
3 members · 4 buys / 3 sells
DateMemberType AmountDisclosed
May 27, 2026 Ro KhannaDHouse Spouse account · DexCom Inc BUY $1K–$15K Jun 9, 2026 +13d
May 15, 2026 Ro KhannaDHouse Spouse account · DexCom Inc SELL $1K–$15K Jun 9, 2026 +25d
May 7, 2026 Michael McCaulRHouse Spouse account · DexCom Inc SELL $1K–$15K Jun 10, 2026 +34d
May 1, 2026 Ro KhannaDHouse Child account · DexCom Inc BUY $1K–$15K Jun 9, 2026 +39d
Apr 13, 2026 Ro KhannaDHouse Spouse account · DexCom Inc BUY $1K–$15K May 11, 2026 +28d
Feb 4, 2026 Michael McCaulRHouse Spouse account · DexCom Inc SELL $1K–$15K Mar 12, 2026 +36d
Jan 26, 2026 John BoozmanRSenate Joint account · DexCom Inc BUY $1K–$15K Feb 15, 2026 +20d

Short side

FINRA· Oct 30, 2026
15,933,006
shares short
+1.6%
vs prior settlement
2.8
days to cover
≈4.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 10, 2026 SEC
State Street Corp disclosed a 5% passive beneficial ownership stake in Dexcom Inc via Schedule 13G, holding…
SC 13G · Impact 3/10
Nov 8, 2026 Insider
Leach Jacob Steven surrendered for taxes 1,451 shares
President, CEO, and Director @ $79.41 ($115.2K)
Nov 8, 2026 Insider
Brown Michael Jon surrendered for taxes 1,451 shares
EVP Chief Legal Compliance Off @ $79.41 ($115.2K)
Nov 8, 2026 Insider
Stern Sadie surrendered for taxes 1,451 shares
EVP Chief People & Culture Off @ $79.41 ($115.2K)
Nov 2, 2026 SEC
In Q3 2026, three small asset managers added DXCM positions totaling $8.7M while four larger asset managers trimmed…
INST-CLUSTER · Impact 3/10
Oct 29, 2026 SEC
Dexcom reported Q3 2026 revenue of $1.344B (up 11% YoY), above the $1.33B consensus, and non-GAAP EPS of $0.73, above…
8-K · Impact 6/10
Oct 22, 2026 Earnings calendar
DXCM Q3 2026 Earnings Scheduled, 2026-10-22
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP · DOUBLED
6,873,273 shares ($462.9M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 22, 2026
Earnings date
DXCM Q3 2026 Earnings Scheduled, 2026-10-22
Jul 30, 2026
Earnings date
DXCM Q2 2026 Earnings Scheduled, 2026-07-30
Apr 30, 2026
Earnings date
DXCM Q1 2026 Earnings Scheduled, 2026-04-30
Mar 24, 2026
Short interest
FTD: DXCM, 145,266 shares ($9.6M) failed to deliver
Settlement: 20260324, Price: $65.94, FTD Value: $9,578,840.04, DEXCOM, INC
Mar 23, 2026
Short interest
FTD: DXCM, 487,024 shares ($32.6M) failed to deliver
Settlement: 20260323, Price: $66.95, FTD Value: $32,606,256.8, DEXCOM, INC

SecBot reports

16 filings · 1 bullish · 1 bearish · 1 mixed · 13 neutral
All DXCM filing & press-release reports (16)